Related Experiment Videos
Tumour markers for ovarian cancer
1Department of Medical Oncology, C.R.C. Laboratories, Charing Cross Hospital, London, U.K.
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.
British journal of cancer·2010
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2002
Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
High levels of hCG in choriocarcinoma can result in renal failure and a false-negative pregnancy test in men.
Clinical oncology (Royal College of Radiologists (Great Britain))·2001
Circulating tumour markers in ovarian tumours.
Forum (Genoa, Italy)·2001
Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.
European journal of cancer (Oxford, England : 1990)·2026
Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.
European journal of cancer (Oxford, England : 1990)·2026
Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients.
European journal of cancer (Oxford, England : 1990)·2026
Evaluating safety: Number needed to harm analyses of androgen receptor inhibitors in advanced prostate cancer.
European journal of cancer (Oxford, England : 1990)·2026
Integrating patient preferences into clinical trial outcomes for older adults with cancer: A perspective from the EORTC Older Adult Council and Quality of Life Group.
European journal of cancer (Oxford, England : 1990)·2026
Immune remodelling and molecular profiling of progressive brain metastases following cranial radiotherapy.
European journal of cancer (Oxford, England : 1990)·2026